Search Results 8051-8060 of 40236 for oral
... oral agents for the treatment of CD (ADT-inadequate responder [IR]) as defined in the protocol. Exclusion Criteria: Has complications of CD, such as ...
... oral study treatment(s) * Has an active infection requiring systemic therapy * Has received prior treatment with a PRMT5 inhibitor or a MAT2A inhibitor
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating the ...
Journal of Oral and Maxillofacial Surgery. 2023; https://www.clinicalkey.com. Accessed July 3, 2024. Medical review (expert opinion). Mayo Clinic. Aug. 29 ...
Oral and Maxillofacial Oncology and Reconstruction Clinic · Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota ...
Patients on chronic oral steroid therapy. Prisoners and institutionalized patients. Patients at very high risk of bleeding due to elevated bleeding profile ...
Sexually active females, unless surgically sterile or at least 2 years post-menopausal, must be using a highly effective contraception (including oral ...
Ability to ingest oral medications. Exclusion Criteria: Has Ocular Melanoma; Has received prior systemic treatment for unresectable or metastatic melanoma ...
The purpose of this study is to evaluate the safety, tolerability, and effectiveness of oral KPT-9274 for the treatment of patients who have advanced solid ...
Learn what healthcare professionals look for when diagnosing mouth cancer. Find out about oral cancer treatments, including surgery, chemotherapy and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!